Biomerica Non Current Assets Total from 2010 to 2024
BMRA Stock | USD 0.71 0.01 1.39% |
Non Current Assets Total | First Reported 1986-05-31 | Previous Quarter 1.6 M | Current Value 1.5 M | Quarterly Volatility 684.4 K |
Check Biomerica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomerica main balance sheet or income statement drivers, such as Depreciation And Amortization of 213.2 K, Interest Expense of 32.2 K or Selling General Administrative of 6.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.75, Dividend Yield of 0.0 or PTB Ratio of 2.33. Biomerica financial statements analysis is a perfect complement when working with Biomerica Valuation or Volatility modules.
Biomerica | Non Current Assets Total |
Latest Biomerica's Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of Biomerica over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Biomerica's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomerica's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
Timeline |
Biomerica Non Current Assets Total Regression Statistics
Arithmetic Mean | 1,397,541 | |
Geometric Mean | 1,246,287 | |
Coefficient Of Variation | 46.67 | |
Mean Deviation | 536,414 | |
Median | 1,343,338 | |
Standard Deviation | 652,267 | |
Sample Variance | 425.5B | |
Range | 2.2M | |
R-Value | 0.53 | |
Mean Square Error | 330B | |
R-Squared | 0.28 | |
Significance | 0.04 | |
Slope | 77,137 | |
Total Sum of Squares | 6T |
Biomerica Non Current Assets Total History
About Biomerica Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Biomerica income statement, its balance sheet, and the statement of cash flows. Biomerica investors use historical funamental indicators, such as Biomerica's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Biomerica investors may use each financial statement separately, they are all related. The changes in Biomerica's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomerica's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biomerica Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biomerica. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Non Current Assets Total | 1.9 M | 1.3 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomerica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomerica's short interest history, or implied volatility extrapolated from Biomerica options trading.
Pair Trading with Biomerica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomerica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will appreciate offsetting losses from the drop in the long position's value.Moving together with Biomerica Stock
0.74 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
0.76 | NRC | National Research Corp | PairCorr |
Moving against Biomerica Stock
0.68 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
0.61 | NXL | Nexalin Technology | PairCorr |
0.48 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.
The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomerica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biomerica Correlation against competitors. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.323 | Quarterly Revenue Growth (0.09) | Return On Assets (0.43) | Return On Equity (0.92) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.